1789 — ScinoPharm Taiwan Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual balance sheet for ScinoPharm Taiwan, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3,477	4,089	4,132	4,346	3,942
Net Total Accounts Receivable
Net Total Receivables	670	473	393	654	813
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,407	5,916	5,967	6,320	6,381
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,192	4,975	4,883	4,797	4,578
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	11,675	11,847	11,691	11,911	11,722
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	742	687	556	803	729
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	1,415	1,317	1,180	1,461	1,357
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	10,260	10,529	10,511	10,450	10,364
Total Liabilities & Shareholders' Equity	11,675	11,847	11,691	11,911	11,722
Total Common Shares Outstanding